RYOJ - Indikator likuiditas cepet rYojbaba Co Ltd

rYojbaba Co Ltd (RYOJ) is rapidly expanding its network of specialized centers, implementing unified therapy standards to optimize operations. Regarding support, the business relies on external IT contractors and diagnostic services while maintaining internal control over treatment. This price chart reflects the current coefficient 2.62. The development vector is focused on expansion in China through digitalization and the synthesis of classical medicine with innovation.

The stability of the closed clinic network of rYojbaba Co Ltd (RYOJ) makes cash flows predictable but limits rapid scaling opportunities. This critical liquidity ratio assesses the company's ability to meet short-term obligations by excluding illiquid inventories and accounting only for cash and accounts receivable, allowing investors to identify hidden financial imbalances and evaluate the business's real margin of safety.